Carl Zeiss Meditec AG : The trendline as bullish argument
Entry price | Target | Stop-loss | Potential |
---|
€0 |
€0 |
€22.3 |
+-NaN% |
---|
The EUR 22.8 support, currently tested, should allow Carl Zeiss Meditec to rally again.
In the recent months, the average target price are regularly revised upward.
After several sessions of correction, the stock is coming back close to the short-term support and its trendline.
Moving averages are flat and the momentum is neutral in the long-term. The EUR 22.8 area could cause a positive reaction for the coming trading sessions and allow a technical rebound towards the EUR 24 mid-term resistance and then the long-term resistance at EUR 26.8.
So as to make the most of a potential technical rebound of Carl Zeiss Meditec, it seems opportune to take a long position at the current price. A confirmation of this pattern would enable the security to reach the EUR 24 resistance. Investors should not insist under EUR 22.5 and are better of placing a stop loss order under this threshold.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.